Immunogenicity & Bioassays

Ensuring the Safety and Efficacy of Biologics

This year's Immunogenicity & Bioassay Stream focuses on the latest science, technologies and strategies to ensure the safety and efficacy of novel biologics, with particular focus on immunogenicity clinical management and assay life cycles. Part One looks at new case studies and how to use immunogenicity data in clinical settings; Part Two examines immunogenicity assessment for novel biologics such as ADCs, bispecifics, CAR-T and mAbs along with an emphasis on new regulatory guideline for cell and gene therapies; and Part Three will showcase emerging technologies and strategies for day-to-day challenges when developing bioassays to evaluate potency, function and robustness of novel biologics.

Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean




Premier Sponsors


View By: